Keyword: AstraZeneca


AstraZeneca to Build $1.5 Billion ADC Production Facility in Singapore

22.05.2024 -

In a move to enhance global supply of its antibody drug conjugates (ADCs) portfolio, AstraZeneca intends to build a $1.5 billion facility in Singapore for the...


AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4 Billion

25.03.2024 -

AstraZeneca has agreed to acquire Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).


AstraZeneca to Buy Amolyt Pharma for up to $1.05 Billion

15.03.2024 -

Britain's AstraZeneca is to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases, more than $1...


AstraZeneca Plans £650 Million Investment in UK

07.03.2024 -

AstraZeneca, whose CEO Pascal Soriot has been critical of the UK business environment for the life sciences industry in the past, wants to invest a large sum at its...


AstraZeneca Completes Acquisitions of Gracell and Icosavax

23.02.2024 -

Within a few days, Anglo-Swedish drugmaker AstraZeneca has completed the acquisitions of Gracell Biotechnologies and Icosavax. Both transactions were announced in...


AstraZeneca to Construct New US Cell Therapy Facility

08.02.2024 -

In a move to launch its cell therapy platforms for critical cancer trials in the US, AstraZeneca is investing $300 million in a new facility in Rockville, Maryland. The...


AstraZeneca to Buy Cell Therapy Developer Gracell for Up to $1.2 Billion

03.01.2024 -

AstraZeneca has agreed to acquire Gracell Biotechnologies, a Chinese developer of cell therapies for the treatment of cancer and autoimmune diseases, for up to $1.2...


AstraZeneca to Buy Vaccine Company Icosavax for $1.1 Billion

14.12.2023 -

AstraZeneca has entered into an agreement to acquire Icosavax, a US biopharmaceutical company based in Seattle in a deal worth up to $1.1 billion. The company focuses on...